FIS
FCPM III Services Portfolio holdings
AUM
$722M
1-Year Est. Return
73.61%
This Fund
S&P 500
1 Year Est. Return
+73.61%
AUM
$722M
AUM Growth
-$40.7M
(-5.3%)
Holding
11
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
NewAmsterdam Pharma
NAMS
$3.82B
| $294M | 40.77% |
9,198,900
|
|
||
2
Dyne Therapeutics
DYN
$3.04B
| $84.2M | 11.66% |
4,644,386
-818,460
|
|
||
3
Vor Biopharma
VOR
$776M
| $73.5M | 10.17% |
4,117,354
+500,000
|
|
||
4
enGene Therapeutics
ENGN
$115M
| $65.6M | 9.08% |
9,632,561
|
|
||
|
MPLT
5
MapLight Therapeutics
MPLT
$1.36B
| $65.6M | 9.08% |
3,226,400
|
|
||
|
DMRA
6
Damora Therapeutics
DMRA
$1.37B
| $63.2M | 8.75% |
+2,441,000
|
|
||
|
CBIO
7
Crescent Biopharma
CBIO
$509M
| $30.8M | 4.27% |
1,677,852
|
|
||
8
Replimune Group
REPL
$815M
| $21.5M | 2.97% |
2,808,368
|
|
||
|
BCYC
9
Bicycle Therapeutics
BCYC
$298M
| $16.1M | 2.23% |
3,468,430
|
|
||
|
10
enGene Therapeutics Warrants
ENGNW
| $7.28M | 1.01% |
2,878,148
|
|
||
|
RAPT
11
DELISTED
RAPT Therapeutics
RAPT
| – | – |
-1,833,333
|
|